---
figid: PMC6823243__fimmu-10-02468-g0003
figtitle: SHP-2 in cytokine receptor signaling
organisms:
- Homo sapiens
- Macaca fascicularis
- Mus musculus
- Drosophila melanogaster
- Panthera pardus
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
- Mus musculus
- Macaca fascicularis
- Panthera pardus
- Danio rerio
pmcid: PMC6823243
filename: fimmu-10-02468-g0003.jpg
figlink: /pmc/articles/PMC6823243/figure/F3/
number: F3
caption: SHP-2 in cytokine receptor signaling. Cytokine binding to the receptor induces
  formation of the SHP-2-containing complex. Besides being involved in the activation
  of ERK, SHP-2 can modulate phosphoinositide 3-kinase (PI3K) activity. PI3K mediates
  the conversion of phosphatidylinositol 4,5-bisphosphate (PI4,5P2) into phosphatidylinositol
  3,4,5-trisphosphate (PI3,4,5P3), which leads to phosphoinositide-dependent kinase
  1 (PDK1) recruitment, AKT phosphorylation, and mammalian target of rapamycin (mTOR)
  activation. Residues phosphorylated by janus kinases (JAKs) in the cytoplasmic portion
  of the receptor act as binding sites for signal transducers and activators of transcription
  (STAT) proteins, that are further phosphorylated by JAKs, allowing dimerization
  and nuclear translocation. This pathway can also be modulated by SHP-2.
papertitle: SHP-2 in Lymphocytes' Cytokine and Inhibitory Receptor Signaling.
reftext: Charl√®ne Niogret, et al. Front Immunol. 2019;10:2468.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9503182
figid_alias: PMC6823243__F3
figtype: Figure
redirect_from: /figures/PMC6823243__F3
ndex: 10777c17-dec9-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6823243__fimmu-10-02468-g0003.html
  '@type': Dataset
  description: SHP-2 in cytokine receptor signaling. Cytokine binding to the receptor
    induces formation of the SHP-2-containing complex. Besides being involved in the
    activation of ERK, SHP-2 can modulate phosphoinositide 3-kinase (PI3K) activity.
    PI3K mediates the conversion of phosphatidylinositol 4,5-bisphosphate (PI4,5P2)
    into phosphatidylinositol 3,4,5-trisphosphate (PI3,4,5P3), which leads to phosphoinositide-dependent
    kinase 1 (PDK1) recruitment, AKT phosphorylation, and mammalian target of rapamycin
    (mTOR) activation. Residues phosphorylated by janus kinases (JAKs) in the cytoplasmic
    portion of the receptor act as binding sites for signal transducers and activators
    of transcription (STAT) proteins, that are further phosphorylated by JAKs, allowing
    dimerization and nuclear translocation. This pathway can also be modulated by
    SHP-2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - hop
  - bsk
  - ras
  - Ras64B
  - Ras85D
  - Sos
  - Shc
  - drk
  - Lamtor2
  - Pdk1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - csw
  - Raf
  - Akt
  - Dsor1
  - Mtk
  - Stat92E
  - Mtor
  - Tor
  - Erk7
  - rl
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - KRAS
  - HRAS
  - NRAS
  - XYLT2
  - SOS1
  - SOS2
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - GRB2
  - PI3
  - CDKN2A
  - S100A9
  - CDK2AP2
  - SUB1
  - RPP14
  - LAMTOR2
  - SF3B6
  - H3P8
  - PDK1
  - PDPK1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTPN11
  - A1BG
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - SERPINA4
  - Hras
  - Kras
  - Rem1
  - Shc1
  - Grb2
  - Serpina1c
  - Pcolce
  - S100a9
  - Pdpk1
  - Pik3r1
  - Ptpn11
  - Zhx2
  - Akt1
  - Mdk
  - Ephb2
  - Mapk1
  - Serpina1d
  - kita
  - ngfra
  - rab1ab
  - grb2b
  - pdk1
  - ptpn11a
  - stat1b
  - stat4
  - mtor
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
